NEU 3.37% $20.53 neuren pharmaceuticals limited

ANAVEX MEETS ENDPOINTS PHASE2 RETT, page-36

  1. 12 Posts.
    lightbulb Created with Sketch. 2
    Sabine - There are two observations I would make:-

    1. Feuerstein is a widely read and clearly very influential commentator, and

    2. a company going on the defensive as Anavex did is never ever a good sign (you may be familiar with the Streisand effect)
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.